Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
about
"The Good, the Bad and the Ugly" of ChitosansInhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches.Chronic lung infection by Pseudomonas aeruginosa biofilm is cured by L-Methionine in combination with antibiotic therapy.Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.A highly adhesive and naturally derived sealant.Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.Insights into host-pathogen interactions from state-of-the-art animal models of respiratory Pseudomonas aeruginosa infections.Energy-triggered drug release from polymer nanoparticles for orthopedic applications.From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.Dendrimer-based selective autophagy-induction rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection in cystic fibrosis.Free and Nanoencapsulated Tobramycin: Effects on Planktonic and Biofilm Forms of Pseudomonas.Targeting microbial biofilms: current and prospective therapeutic strategies.Nanodelivery strategies for the treatment of multidrug-resistant bacterial infectionsStandardization of Larvae to Provide Reliable and Reproducible Results in the Study of Fungal Pathogens
P2860
Q26747664-3F085D0E-B0BB-42BE-809E-4CEBDCFE4705Q28077482-27DDAB01-14E7-403D-98EF-98E1960D501FQ36237869-9CAC5598-F97B-4412-9267-B8FB1F4D09CBQ38599969-1F14893E-1C51-46D0-84D6-57C1649E45F8Q38710940-B8C1116A-2390-4B01-9F19-062FEE6F01C5Q38789348-F2214399-0497-4CA5-9224-4CD021012069Q38978571-B5B4E871-19A6-4BA4-A1AC-238EE1750466Q39041192-B3C0C120-54E2-4A37-AEC4-68B86D115726Q39248419-4ADC2D0F-BDF7-4EB2-B87E-5523475FF57AQ40048899-598D7FE9-8D32-4CAE-A3FC-E5DC6ABCA106Q40149011-3F00B10C-6B34-432F-B677-54F68362318FQ47637669-2180DC46-0A38-43F9-A4AB-79F529A8F6FFQ58693503-21E61194-2DC4-4F08-9988-835FDF250E0EQ58761035-24869854-49FF-4E34-A6D5-143C04620DB0
P2860
Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Antimicrobial efficacy of tobr ...... ion with dornase alfa (DNase).
@en
type
label
Antimicrobial efficacy of tobr ...... ion with dornase alfa (DNase).
@en
prefLabel
Antimicrobial efficacy of tobr ...... ion with dornase alfa (DNase).
@en
P2093
P50
P1476
Antimicrobial efficacy of tobr ...... ion with dornase alfa (DNase).
@en
P2093
Brendan F Gilmore
Christopher J Scott
Daniela Schmid
David S Jones
Derek J Quinn
Jill Deacon
Sharif M Abdelghany
P356
10.1016/J.JCONREL.2014.11.022
P407
P577
2014-12-04T00:00:00Z